FI943625A0 - Menetelmiä tulehduksellisten ihotautien hoitamiseksi - Google Patents

Menetelmiä tulehduksellisten ihotautien hoitamiseksi

Info

Publication number
FI943625A0
FI943625A0 FI943625A FI943625A FI943625A0 FI 943625 A0 FI943625 A0 FI 943625A0 FI 943625 A FI943625 A FI 943625A FI 943625 A FI943625 A FI 943625A FI 943625 A0 FI943625 A0 FI 943625A0
Authority
FI
Finland
Prior art keywords
procedures
treatment
skin diseases
inflammatory skin
inflammatory
Prior art date
Application number
FI943625A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943625L (fi
FI943625A7 (fi
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Publication of FI943625L publication Critical patent/FI943625L/fi
Publication of FI943625A7 publication Critical patent/FI943625A7/fi
Publication of FI943625A0 publication Critical patent/FI943625A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI943625A 1992-02-07 1993-01-29 Menetelmiä tulehduksellisten ihotautien hoitamiseksi FI943625A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83282892A 1992-02-07 1992-02-07
PCT/US1993/001043 WO1993015740A1 (en) 1992-02-07 1993-01-29 Methods of treating inflammatory dermatoses

Publications (3)

Publication Number Publication Date
FI943625L FI943625L (fi) 1994-08-04
FI943625A7 FI943625A7 (fi) 1994-08-04
FI943625A0 true FI943625A0 (fi) 1994-08-04

Family

ID=25262717

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943625A FI943625A0 (fi) 1992-02-07 1993-01-29 Menetelmiä tulehduksellisten ihotautien hoitamiseksi

Country Status (12)

Country Link
US (1) US5998395A (forum.php)
EP (1) EP0625045A4 (forum.php)
JP (1) JP2927961B2 (forum.php)
KR (1) KR100282575B1 (forum.php)
AU (1) AU667519B2 (forum.php)
CA (1) CA2129114A1 (forum.php)
CZ (1) CZ188394A3 (forum.php)
FI (1) FI943625A0 (forum.php)
NO (1) NO942913L (forum.php)
NZ (1) NZ249379A (forum.php)
WO (1) WO1993015740A1 (forum.php)
ZA (1) ZA93811B (forum.php)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202935T1 (de) * 1992-09-11 2001-07-15 Sandra Brown Verfahren zur behandlung von haarausfall
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1996034601A1 (en) * 1995-05-05 1996-11-07 Braiman Mark S Treatment of psoriasis with 11-cis-retinoic acid
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
US6355669B1 (en) * 1997-10-22 2002-03-12 Eisai Co., Ltd. Retinoic acid agonists as preventive and therapeutic agents for nephritis
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
RU2283098C2 (ru) * 2000-05-09 2006-09-10 Канека Корпорейшн Кожные композиции, содержащие кофермент q в качестве активного ингредиента
AU2001290816A1 (en) 2000-09-13 2002-03-26 Bristol-Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
WO2002071025A2 (en) * 2001-03-02 2002-09-12 Spectra Systems Corporation Combinatorial chemistry and compound identification system
ES2188426B1 (es) * 2001-12-12 2004-11-16 Rosalia Pidal Fernandez Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
US20030199488A1 (en) * 2002-04-23 2003-10-23 Trotta Gina M. Treatment of hyperproliferative disorders/inflammatory dermatoses
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
EP1567113A4 (en) * 2002-10-24 2006-11-08 G & R Pharmaceuticals Llc ANTIFUNGAL PREPARATIONS
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
DE602004031356D1 (de) * 2003-11-21 2011-03-24 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
AU2005213895A1 (en) * 2004-02-19 2005-09-01 Chemaphor Inc. Topical formulations for the treatment of skin conditions
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
US8211461B2 (en) 2004-09-28 2012-07-03 Chemaphor Inc. Compositions and methods for promoting weight gain and feed conversion
US20070009607A1 (en) * 2005-07-11 2007-01-11 George Jones Antibacterial/anti-infalmmatory composition and method
JP2011500733A (ja) 2007-10-26 2011-01-06 ケマファー インコーポレーテッド 免疫応答を増強するための組成物および方法
ES2327201B1 (es) 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
US10456369B2 (en) 2009-04-30 2019-10-29 Avivagen Inc. Methods and compositions for improving the health of animals
EP2490542A4 (en) 2009-10-20 2015-12-30 Discovery Partners Llc DERMATOLOGICAL AND COSMETIC COMPOSITIONS
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
MX392053B (es) * 2017-09-28 2025-03-21 Johnson & Johnson Consumer Inc Composiciones cosmeticas y metodo para tratar la piel
RU2712281C1 (ru) * 2018-11-23 2020-01-28 Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
ZA77678B (en) * 1977-02-07 1978-09-27 S Fourie Pharmaceutical composition and use thereof
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy

Also Published As

Publication number Publication date
NZ249379A (en) 1998-07-28
EP0625045A4 (en) 1995-01-18
US5998395A (en) 1999-12-07
EP0625045A1 (en) 1994-11-23
AU3585493A (en) 1993-09-03
FI943625L (fi) 1994-08-04
KR100282575B1 (ko) 2001-02-15
AU667519B2 (en) 1996-03-28
WO1993015740A1 (en) 1993-08-19
KR950700069A (ko) 1995-01-16
NO942913L (no) 1994-10-05
JPH07505617A (ja) 1995-06-22
CA2129114A1 (en) 1993-08-19
CZ188394A3 (en) 1996-02-14
NO942913D0 (forum.php) 1994-08-05
FI943625A7 (fi) 1994-08-04
JP2927961B2 (ja) 1999-07-28
ZA93811B (en) 1993-09-10

Similar Documents

Publication Publication Date Title
FI943625A0 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
KR100344712B1 (ko) 알러지성및염증성질환의치료에유용한화합물
FI943805L (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
FI910413A7 (fi) Tooppiset valmisteet ihmisen kynsien hoitamiseksi
FI933902A7 (fi) Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
FI962370A0 (fi) Laite tissuen valmistamiseksi
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
FI971527A7 (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
KR930702990A (ko) 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI925544A7 (fi) Bentsoehappojohdannaisia leukotrieeniin liittyvien sairauksien hoitami seen
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO942756D0 (no) Behandling av glaucoma
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
FI102810B1 (fi) Aine eläimen ihon käsittelyyn
ZA936136B (en) Treatment of skin diseases
DE69125969D1 (de) Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen
KR970020845U (ko) 근골격계질환 치료보조용 테이프